PERSISTENT2021-01-012021-03-31in-bse-fin:OneOperatingExpenses01Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneOperatingExpenses02Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneOperatingExpenses03Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneOperatingExpenses04Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneOperatingExpenses05Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneOperatingExpenses06Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneOperatingExpenses07Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneOperatingExpenses08Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneOperatingExpenses09Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneOperatingExpenses10Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourOperatingExpenses01Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourOperatingExpenses02Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourOperatingExpenses03Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourOperatingExpenses04Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourOperatingExpenses05Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourOperatingExpenses06Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourOperatingExpenses07Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourOperatingExpenses08Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourOperatingExpenses09Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourOperatingExpenses10Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentRevenue01Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentRevenue02Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentRevenue03Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourReportableSegmentRevenue01Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourReportableSegmentRevenue02Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourReportableSegmentRevenue03Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentResults01Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentResults02Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentResults03Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourReportableSegmentResults01Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourReportableSegmentResults02Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourReportableSegmentResults03Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentAssets01Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentAssets02Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentAssets03Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentLiabilities01Member PERSISTENT2021-03-31in-bse-fin:OneReportableSegmentLiabilities01Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentLiabilities02Member PERSISTENT2021-03-31in-bse-fin:OneReportableSegmentLiabilities02Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneReportableSegmentLiabilities03Member PERSISTENT2021-03-31in-bse-fin:OneReportableSegmentLiabilities03Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PERSISTENT2021-01-012021-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member PERSISTENT2021-01-012021-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares PERSISTENT 2020-04-01 2021-03-31 2021-04-16 INR Millions Yearly true Cash Flow Indirect Multi segment 2021-01-01 2021-03-31 Audited Consolidated 11133580000.00 400360000.00 11533940000.00 0.00 0.00 0.00 8397030000.00 15830000.00 419050000.00 853250000.00 9685160000.00 1848780000.00 0.00 1848780000.00 499350000.00 -28160000.00 471190000.00 0.00 1377590000.00 0.00 0.00 0.00 0.00 1377590000.00 91420000.00 1469010000.00 1377590000.00 0.00 1469010000.00 0.00 764250000.00 10 18.03 18.03 0.00 0.00 18.03 18.03 0.00 1. The audited condensed consolidated financial statements for the quarter and year ended March 31, 2021, have been approved by the Board of Directors at its meeting held on April 29, 2021, and as recommended by the Audit Committee at its meeting held on April 28, 2021. The statutory auditors have expressed an unqualified audit opinion. The information presented above is extracted from the audited condensed consolidated financial statements. 2. The Board of Directors at its meeting held in January 2021 had approved payment of Interim Dividend of INR 14 per Equity Share of INR 10 each for FY 2020-21. Accordingly, during February 2021, INR 985,238,750 (after Tax Deducted at Source) were paid towards the above Dividend and INR 84,711,250 towards Tax Deducted at Source. 3. The Board of Directors at its meeting held on April 29, 2021, recommended Final Dividend of INR 6 per share for the Financial Year 2020-21. This Final Dividend is subject to the approval of Members at the ensuing 31st Annual General Meeting which will be held on or before September 30, 2021. 4. Persistent Systems Inc., USA, the wholly owned subsidiary of the Company formed Persistent Systems S.r.l., Italy on March 23, 2021. 5. The Group has considered the possible effects that may result from COVID-19 in the preparation of these condensed consolidated financial statements including the recoverability of carrying amounts of financial and non financial assets. In developing the assumptions relating to the possible future uncertainties in the global economic conditions because of COVID-19, the Group has, at the date of approval of these condensed consolidated financial statements, used internal and external sources of information including internal credit evaluation report and related information and economic forecasts and expects that the carrying amount of these assets will be recovered. The impact of COVID-19 on the Group's condensed interim consolidated financial statements may differ from that estimated as at the date of approval of these condensed consolidated financial statements. 6. The code on Social security, 2020 (applicable to Companies incorpoarated in India) relating to employee benefits has been approved by the Parliament and has also been published in Official Gazette of India. However, the date on which it comes into effect has not been notified and the rules are yet to be framed. Group will complete its evaluation and will give appropriate impact in its financial results in the period in which, the Code becomes effective and the related rules are published. 7.The investors are requested to visit the following website of the Company and Stock Exchanges for further details: Company's website: https://www.persistent.com/investors BSE Ltd: www.bseindia.com National Stock Exchange of India Ltd.: www.nseindia.com Debt Equity: 0.00165 Debt service coverage: 3648 times Interest service coverage: 13769 times Multi segment 2020-04-01 2021-03-31 Audited Consolidated 41878880000.00 1077720000.00 42956600000.00 0.00 0.00 0.00 30721670000.00 57940000.00 1755500000.00 4327060000.00 36862170000.00 6094430000.00 0.00 6094430000.00 1784590000.00 -196930000.00 1587660000.00 0.00 4506770000.00 0.00 0.00 0.00 0.00 4506770000.00 373720000.00 4880490000.00 4506770000.00 0.00 4880490000.00 0.00 764250000.00 10 23093300000.00 58.97 58.97 0.00 0.00 58.97 58.97 0.00 Communication expenses 12950000.00 Electricity expenses (net) 20240000.00 Internet link expenses 15240000.00 Legal and professional fees 135380000.00 Other Expenses 228600000.00 Purchase of software licenses 329960000.00 Recruitment expenses 31630000.00 Royalty expenses 41070000.00 Training and seminars 8580000.00 Travelling and conveyance 29600000.00 Communication expenses 102180000.00 Electricity expenses (net) 82580000.00 Internet link expenses 70860000.00 Legal and professional fees 514810000.00 Other Expenses 1240100000.00 Purchase of software licenses 1855620000.00 Recruitment expenses 135100000.00 Royalty expenses 94830000.00 Training and seminars 57360000.00 Travelling and conveyance 173620000.00 - BFSI 3328540000.00 - Healthcare & Life Sciences 2150230000.00 - Technology Companies and n Emerging Verticals 5654810000.00 - BFSI 12857050000.00 - Healthcare & Life Sciences 8104240000.00 - Technology Companies and n Emerging Verticals 20917590000.00 11133580000.00 41878880000.00 0.00 0.00 11133580000.00 41878880000.00 - BFSI 1251660000.00 - Healthcare & Life Sciences 1046960000.00 - Technology Companies and n Emerging Verticals 1622560000.00 - BFSI 4818380000.00 - Healthcare & Life Sciences 3982470000.00 - Technology Companies and n Emerging Verticals 6449400000.00 3921180000.00 15250250000.00 15830000.00 57940000.00 2056570000.00 Note for segemnt wise information: Operating segments are components of an enterprise for which discrete financial information is available that is evaluated regularly by the chief operating decision makers, in deciding how to allocate resources and assessing performance. The Group's chief operating decision makers are the Chief Executive Officer and Chairman & Managing Director. Segment wise capital employed: Segregation of assets (other than trade receivables and unbilled revenue), liabilities, depreciation and amortization and other non-cash expenses into various reportable segments have not been presented as the assets and liabilities are used interchangeably among segments and the Group is of the view that it is not practical to reasonably allocate the other assets, liabilities and other non-cash expenses to individual segments and an ad-hoc allocation will not be meaningful. Considering the focus on industry verticals, the Group has decided to reorganize its operating segments from April 1, 2020. The figures for the corresponding periods / year have been appropriately reclassified in line with the current period's / year's classification. a. Banking, Financial Services and Insurance (BFSI) b. Healthcare & Life Sciences c. Technology Companies and Emerging Verticals 9097880000.00 1848780000.00 6094430000.00 - BFSI 1950450000.00 - Healthcare & Life Sciences 1525690000.00 - Technology Companies and n Emerging Verticals 4405600000.00 7881740000.00 28773500000.00 36655240000.00 - BFSI 0.00 - Healthcare & Life Sciences 0.00 - Technology Companies and n Emerging Verticals 0.00 0.00 36655240000.00 36655240000.00 57940000.00 0.00 58490000.00 0.00 58260000.00 -76810000.00 -40030000.00 -104230000.00 0.00 715770000.00 0.00 0.00 0.00 1755500000.00 0.00 924950000.00 0.00 0.00 0.00 -61070000.00 0.00 558700000.00 290440000.00 131390000.00 0.00 -479470000.00 0.00 174360000.00 0.00 2846790000.00 8941220000.00 0.00 0.00 0.00 1581970000.00 0.00 7359250000.00 0.00 417570000.00 350530000.00 712180000.00 0.00 0.00 0.00 0.00 30020000.00 1281040000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 366290000.00 0.00 -3721880000.00 0.00 -5385830000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4540000.00 0.00 319110000.00 1069950000.00 58010000.00 0.00 9000000.00 -1442610000.00 530810000.00 -11500000.00 519310000.00 1899990000.00 2419300000.00